Russell P. Pagano

Russell P. Pagano discloses dealings in Biomimetic Therapeutics, Inc. to SEC (Form 4). We count 8 filings; the first trade dates from 18 October 2010 and the latest from 1 March 2013.

In open-market terms, that means 1 purchase worth €11k on one side and 4 sales worth €38k on the other. The net balance comes to €27k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 1 option exercise. 2013 to date brings no purchases and 1 sale.

The latest filing, published on 5 March 2013, reports an option exercise of €111k in Biomimetic Therapeutics, Inc. The last insider purchase was made public on 20 May 2011, 5,636 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.